159 related articles for article (PubMed ID: 20470219)
1. Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas.
Machado AS; Da Silva Robaina MC; Magalhães De Rezende LM; Apa AG; Amoêdo ND; Bacchi CE; Klumb CE
Leuk Lymphoma; 2010 Jun; 51(6):1020-7. PubMed ID: 20470219
[TBL] [Abstract][Full Text] [Related]
2. Can a blood test monitor lymphoma?
Jones K; Gandhi MK
Leuk Lymphoma; 2010 Jun; 51(6):957-9. PubMed ID: 20536342
[No Abstract] [Full Text] [Related]
3. Plasma Epstein Barr virus (EBV) DNA as a biomarker for EBV associated Hodgkin lymphoma.
Dinand V; Sachdeva A; Datta S; Bhalla S; Kalra M; Wattal C; Radhakrishnan N
Indian Pediatr; 2015 Aug; 52(8):681-5. PubMed ID: 26388626
[TBL] [Abstract][Full Text] [Related]
4. Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
Kanakry JA; Li H; Gellert LL; Lemas MV; Hsieh WS; Hong F; Tan KL; Gascoyne RD; Gordon LI; Fisher RI; Bartlett NL; Stiff P; Cheson BD; Advani R; Miller TP; Kahl BS; Horning SJ; Ambinder RF
Blood; 2013 May; 121(18):3547-53. PubMed ID: 23386127
[TBL] [Abstract][Full Text] [Related]
5. Circulating Epstein-Barr virus DNA and cell-free DNA in pediatric lymphomas.
Yalçın B; Kutluk T; Ağbaba SK; Demir Ç; Talim B
Turk J Pediatr; 2020; 62(4):541-550. PubMed ID: 32779406
[TBL] [Abstract][Full Text] [Related]
6. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
7. Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation.
Ruf S; Behnke-Hall K; Gruhn B; Bauer J; Horn M; Beck J; Reiter A; Wagner HJ
J Clin Virol; 2012 Mar; 53(3):186-94. PubMed ID: 22182950
[TBL] [Abstract][Full Text] [Related]
8. Quantification of plasma Epstein-Barr virus DNA for assessing treatment response in a patient with plasmablastic lymphoma.
Law MF; Poon WL; Ng KS; Chan HN; Lai HK; Ha CY; Ng C; Yeung YM; Yip SF
Ann Hematol; 2012 May; 91(5):789-791. PubMed ID: 21881823
[No Abstract] [Full Text] [Related]
9. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
10. Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients.
Au WY; Pang A; Choy C; Chim CS; Kwong YL
Blood; 2004 Jul; 104(1):243-9. PubMed ID: 15031209
[TBL] [Abstract][Full Text] [Related]
11. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.
Wang L; Wang H; Wang JH; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Zhang YJ
Oncotarget; 2015 Oct; 6(30):30317-26. PubMed ID: 26210287
[TBL] [Abstract][Full Text] [Related]
12. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.
Gandhi MK; Lambley E; Burrows J; Dua U; Elliott S; Shaw PJ; Prince HM; Wolf M; Clarke K; Underhill C; Mills T; Mollee P; Gill D; Marlton P; Seymour JF; Khanna R
Clin Cancer Res; 2006 Jan; 12(2):460-4. PubMed ID: 16428487
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma.
Jones K; Nourse JP; Keane C; Crooks P; Gottlieb D; Ritchie DS; Gill D; Gandhi MK
Am J Hematol; 2012 Mar; 87(3):258-65. PubMed ID: 22213215
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
Ito Y; Kimura H; Maeda Y; Hashimoto C; Ishida F; Izutsu K; Fukushima N; Isobe Y; Takizawa J; Hasegawa Y; Kobayashi H; Okamura S; Kobayashi H; Yamaguchi M; Suzumiya J; Hyo R; Nakamura S; Kawa K; Oshimi K; Suzuki R
Clin Cancer Res; 2012 Aug; 18(15):4183-90. PubMed ID: 22675173
[TBL] [Abstract][Full Text] [Related]
16. Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.
Tisi MC; Cupelli E; Santangelo R; Maiolo E; Alma E; Giachelia M; Martini M; Bellesi S; D'Alò F; Voso MT; Pompili M; Leone G; Larocca LM; Hohaus S
Leuk Lymphoma; 2016; 57(3):628-34. PubMed ID: 26458141
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of whole blood Epstein-Barr virus DNA is useful for assessing treatment response in patients with non-Hodgkin's lymphoma.
Jo SA; Hwang SH; Kim SY; Shin HJ; Chung JS; Sol MY; Chang CL; Lee EY
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e106-13. PubMed ID: 19522857
[TBL] [Abstract][Full Text] [Related]
18. Relationship between non-Hodgkin's lymphoma and blood levels of Epstein-Barr virus in children in north-western Tanzania: a case control study.
Kabyemera R; Masalu N; Rambau P; Kamugisha E; Kidenya B; De Rossi A; Petrara MR; Mwizamuholya D
BMC Pediatr; 2013 Jan; 13():4. PubMed ID: 23294539
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.
Hummel M; Anagnostopoulos I; Korbjuhn P; Stein H
J Pathol; 1995 Mar; 175(3):263-71. PubMed ID: 7745495
[TBL] [Abstract][Full Text] [Related]
20. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
